Details for New Drug Application (NDA): 021671
✉ Email this page to a colleague
The generic ingredient in DEPODUR is morphine sulfate. There are twenty-three drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
Summary for 021671
Tradename: | DEPODUR |
Applicant: | Pacira Pharms Inc |
Ingredient: | morphine sulfate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021671
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE, LIPOSOMAL;EPIDURAL | Strength | 10MG/ML (10MG/ML) | ||||
Approval Date: | May 18, 2004 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE, LIPOSOMAL;EPIDURAL | Strength | 15MG/1.5ML (10MG/ML) | ||||
Approval Date: | May 18, 2004 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE, LIPOSOMAL;EPIDURAL | Strength | 20MG/2ML (10MG/ML) | ||||
Approval Date: | May 18, 2004 | TE: | RLD: | No |
Expired US Patents for NDA 021671
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-003 | May 18, 2004 | ⤷ Subscribe | ⤷ Subscribe |
Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-001 | May 18, 2004 | ⤷ Subscribe | ⤷ Subscribe |
Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-002 | May 18, 2004 | ⤷ Subscribe | ⤷ Subscribe |
Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-003 | May 18, 2004 | ⤷ Subscribe | ⤷ Subscribe |
Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-002 | May 18, 2004 | ⤷ Subscribe | ⤷ Subscribe |
Pacira Pharms Inc | DEPODUR | morphine sulfate | INJECTABLE, LIPOSOMAL;EPIDURAL | 021671-003 | May 18, 2004 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription